Back to Search Start Over

NRF3 activates mTORC1 arginine-dependently for cancer cell viability

Authors :
Shuuhei Hirose
Tsuyoshi Waku
Misato Tani
Haruka Masuda
Keiko Endo
Sanae Ashitani
Iori Aketa
Hina Kitano
Sota Nakada
Ayaka Wada
Atsushi Hatanaka
Tsuyoshi Osawa
Tomoyoshi Soga
Akira Kobayashi
Source :
iScience, Vol 26, Iss 2, Pp 106045- (2023)
Publication Year :
2023
Publisher :
Elsevier, 2023.

Abstract

Summary: Cancer cells coordinate the mTORC1 signals and the related metabolic pathways to robustly and rapidly grow in response to nutrient conditions. Although a CNC-family transcription factor NRF3 promotes cancer development, the biological relevance between NRF3 function and mTORC1 signals in cancer cells remains unknown. Hence, we showed that NRF3 contributes to cancer cell viability through mTORC1 activation in response to amino acids, particularly arginine. NRF3 induced SLC38A9 and RagC expression for the arginine-dependent mTORC1 recruitment onto lysosomes, and it also enhanced RAB5-mediated bulk macropinocytosis and SLC7A1-mediated selective transport for arginine loading into lysosomes. Besides, the inhibition of the NRF3–mTORC1 axis impaired mitochondrial function, leading to cancer cell apoptosis. Consistently, the aberrant upregulation of the axis caused tumor growth and poor prognosis. In conclusion, this study sheds light on the unique function of NRF3 in arginine-dependent mTORC1 activation and the pathophysiological aspects of the NRF3–mTORC1 axis in cancer development.

Details

Language :
English
ISSN :
25890042
Volume :
26
Issue :
2
Database :
Directory of Open Access Journals
Journal :
iScience
Publication Type :
Academic Journal
Accession number :
edsdoj.94a3d01baf604a83a67455cb7ad7597c
Document Type :
article
Full Text :
https://doi.org/10.1016/j.isci.2023.106045